SKML, NL-NEQAS, Nijmegen, The Netherlands.
Clin Chem Lab Med. 2010 Jul;48(7):1021-7. doi: 10.1515/CCLM.2010.226.
Point-of-care glucose meters are used increasingly in semi- and non-professional context. The quality of glucose measurements depends on the quality of the equipment, the quality of use, and the pre-analytical conditions. In this article, a External Quality Assessment Scheme (SKML)-Quality Mark for point-of-care test (POCT) and self-test glucose meters is proposed, assessing analytical quality and technical quality. The analytical requirements are based on the biological variation concept, and a system to assess meters for the SKML-Quality Mark is described. Using the proposed system as an example, 14 meters were tested.
The analytical quality of the POCT and self-test equipment was assessed for plasma calibrated glucose values by comparison with a trueness verified method traceable to the IFCC reference method in an accredited clinical laboratory. The concept is based on the biological variation system. The SKML-Quality Mark comprises the following criteria for blood glucose equipment: 1) Fulfilment of compliance with ISO 15197 and/or TNO guideline criterion; 2) Fulfilment of the total allowable error (TAE) criterion; 3) Fulfilment of the total allowable linearity bias criterion; 4) Fulfilment of the total allowable interfering substances bias criterion; and 5) Fulfilment of the haematocrit criterion.
The proposed SKML-Quality Mark system was tested on 14 commercial home-use meters. The TAE criterion is violated by two meters. The main reason for the violation is bias. For the majority of meters, the Passing and Bablok regression confidence interval does not include the intercept of 0.0 and slope of 1.0. In addition, Syx indicates dispersion around the line or non-linearity. The bias and total error at three different concentrations were investigated as part of the quality mark, resulting in disapproval of the Dicomed Sensocard Plus meter. The bias was significant for the Wellion Linus. With respect to interfering substances, bias of the same magnitude and sign as the bias without additive was seen for all meters for acetaminophen, indicating no additional interference. For ascorbic acid, an additional bias was seen for several meters. However, significant bias was demonstrated for the Sensocard Plus and Glucocard X-meter.
The biological variation concept offers a scientific basis for assessment of acceptable deviation. The concept is extended in the SKML-Quality Mark correcting for the limited number of measurements that can be performed while assessing home-use or POCT meters. The results show that three out of 14 meters fail the proposed quality mark.
即时检验血糖仪在半专业和非专业环境中使用越来越多。血糖测量的质量取决于设备的质量、使用质量和分析前条件。本文提出了一种即时检验血糖仪(POCT)和自我检测血糖仪的外部质量评估计划(SKML)-质量标志,用于评估分析质量和技术质量。分析要求基于生物学变异概念,并描述了一种用于评估 SKML 质量标志的仪表系统。使用所提出的系统作为示例,测试了 14 台仪表。
通过将即时检验和自我检测设备的血浆校准葡萄糖值与经过认证的临床实验室中可溯源至 IFCC 参考方法的准确性验证方法进行比较,评估即时检验和自我检测设备的分析质量。该概念基于生物学变异系统。SKML 质量标志包括以下用于血糖设备的标准:1)符合 ISO 15197 和/或 TNO 准则标准;2)符合总允许误差(TAE)标准;3)符合总允许线性偏差标准;4)符合总允许干扰物质偏差标准;5)符合血细胞比容标准。
在所提出的 SKML 质量标志系统上测试了 14 台商业家用血糖仪。两台血糖仪违反了 TAE 标准。违反的主要原因是偏差。对于大多数仪表,通过 Bablok 回归置信区间不包括 0.0 的截距和 1.0 的斜率。此外,Syx 表示围绕线的分散或非线性。作为质量标志的一部分,研究了三个不同浓度下的偏差和总误差,结果导致 Dicomed Sensocard Plus 血糖仪不合格。Wellion Linus 的偏差显著。关于干扰物质,对于所有血糖仪,在添加物存在的情况下,均观察到与偏差相同幅度和符号的偏差,表明没有额外的干扰。对于抗坏血酸,对于几个血糖仪观察到额外的偏差。然而,在 Sensocard Plus 和 Glucocard X-meter 中,证明了显著的偏差。
生物学变异概念为评估可接受偏差提供了科学依据。该概念在 SKML 质量标志中得到扩展,以纠正在评估家用或 POCT 血糖仪时可以进行的测量次数有限的问题。结果表明,在 14 台仪表中有 3 台不符合拟议的质量标志。